Severance Hospital
Seoul, 120-752, South Korea
NCT Number: NCT01309256
Minimally invasive surgery revolutionized the field of gastric cancer surgery. The surgical robot was introduced to alleviate the difficulty of laparoscopic surgery. Although many studies have reported successful outcomes for robotic surgery, there is no multicenter prospective analysis regarding the advantage of the robotic gastrectomy. The aim of this study is to analyze the surgical outcomes of the robotic gastrectomy focusing on the learning curve, cost-effectiveness, quality of life, and acute-inflammatory reaction in comparison with laparoscopic gastrectomy.
Looking for future studies?
Notify Me20 year and older
All sexes
Observational
Seoul, 120-752, South Korea
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
for prospective study participants
Inclusion criteria
for retrospective study participants
Exclusion criteria
for prospective study participants
Exclusion criteria
for retrospective study participants
Time frame: at the end of the study
Time frame: from the start of the operation to discharge of the patient (usually two weeks after the operation)
Time frame: from admission to discharge of the patient (usually from two days before the operation until two weeks after the operation)
Time frame: One day before operation, first OPD visit after the operation (two weeks after the operation), 3M, 12M, 36M, and 60M after the operation
Time frame: preop, 2hr, 24hr, 4days and 30 days after the operation
Yonsei University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00183898
Digestive System Diseases, Digestive System Neoplasms
Los Angeles, California, United States
View Trial DetailsNCT00342654
Digestive System Diseases, Digestive System Neoplasms
Beijing, China
View Trial DetailsNCT05396300
Colonic Diseases, Colorectal Cancer
Hangzhou, Zhejiang, China
View Trial DetailsNCT05538195
Colon Cancer, Colonic Diseases
Henan, China
View Trial Details